International Isotopes Inc. (INIS)

Market Cap	19.21M
Revenue (ttm)	12.14M
Net Income (ttm)	-845.16K
Shares Out	523.46M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,747
Open	0.0359
Previous Close	0.0360
Day's Range	0.0359 - 0.0400
52-Week Range	0.0200 - 0.0600
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About International Isotopes

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Theranostics Products, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 40
• Stock Exchange: OTCMKTS
• Ticker Symbol: INIS